Phone English: +33 4 57 62 83 79 Français: +33 4 57 62 83 67

As challenging as it may sound, TransCure bioServices has developed the most predictive humanized immune system and liver mouse models designed for optimizing preclinical research in various therapeutic areas and diseases.

Our team of scientific experts has decided to host a series of Webinar sessions to provide you with the keys to a successful preclinical package. 4 sessions to cover many applications such as: Cancer immunotherapy, inflammation, infectious diseases, liver diseases…

Join us for our dynamic 2022 Webinar Series!

hosted by Dr. Sébastien Tabruyn PhD., CSO
& Dr. Kiave Ho Wang Yin PhD., Director of innovation

Who is Sebastien Tabruyn?


Sebastien Tabruyn, PhD Chief Scientific Officer (CSO). He holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.

Who is Kiave Ho Wang Yin?


Kiave-Yune HoWangYin, Ph.D. Director of Innovation. Kiave HoWangYin holds a Ph.D. in Immunology / Oncology from the Paris 7 University (France). She worked for 5 years in the Center of Cardiovascular Research (Paris) as a scientist in the field of inflammation and angiogenesis. She published more than 10 papers in peer-reviewed international journals in oncology and inflammation.

2022 Webinar Series

4 sessions, 4 topics to present to you the numerous applications of the most predictive human immune system and human liver diseases models

Cancer Immunotherapy

Accelerating preclinical drug candidate selection using the advanced fully humanized immune system mouse models


Fully humanized immune system mouse models and translational predictability

Infectious diseases

Humanized immune system and humanized liver mouse models for infectious disease research including HIV and HBV

The human liver chimeric mouse model

A unique tool to study human hepatocyte physiology and pathology


Want to know more and discuss about your own project?

Contact us by email to connect when it matches with your calendar!

Our latest news

TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth

TransCure bioServices Welcomes Cathay Capital to Accelerate Its Ambitious Growth Archamps, June 29th, 2022 – Cathay Capital announced its investment in TransCure bioServices, alongside the management team and Financière Arbevel. With this transaction, TransCure...

TransCure bioServices is AAALAC Accredited

TransCure bioServices receives full AAALAC Accreditation TransCure bioServices is proud to announce that our facility is now fully accredited by the AAALAC, a compelling achievement rewarding hard-work and dedication to the humane and responsible care and use of...

Science VS Sars-Cov-2: science could win

Science could win We all know that 2021 will go into mostly everyone´s history book as the vaccine year against the COVID-19 pandemic.  It made us realize why science is key to understand viruses, bacteria and the interactions between humans and their environment. We...

New Disease Model: human hepatocytes (hu-liver) Mouse Models

TransCure bioServices launches its human hepatocytes (hu-liver) mouse models! Innovative preclinical model thanks to TransCure bioServices ! Our initial human hepatocyte liver disease model (hu-PIRF) has now been fully validated in house thanks to our collaboration...

Our profession:
in vivo pharmacology services

Please feel free to contact us